On the surface, the movement disorder amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, and the cognitive disorder frontotemporal lobar degeneration (FTLD), which underlies frontotemporal dementia, manifest in very different ways. In addition, they are known to primarily affect very different regions of the brain.
First Whole-Genome Sequencing of PSP Nets Six New Risk Loci alzforum.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from alzforum.org Daily Mail and Mail on Sunday newspapers.
Scott Monteith retires from Best-One of Indy tirereview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tirereview.com Daily Mail and Mail on Sunday newspapers.
Scott Monteith, Best-One of Indy co-founder, retires tirebusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tirebusiness.com Daily Mail and Mail on Sunday newspapers.
Scott Monteith Retires From Best-One of Indy moderntiredealer.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moderntiredealer.com Daily Mail and Mail on Sunday newspapers.
New research reveals a type of monoclonal antibody already tested in certain forms of cancer may be a promising treatment in stopping the progression of amyotrophic lateral sclerosis, or ALS, a fatal neurodegenerative disease.
New research reveals a type of monoclonal antibody already tested in certain forms of cancer may be a promising treatment in stopping the progression of amyotrophic lateral sclerosis, or ALS, a fatal neurodegenerative disease.